Xcelience Expands CTS Manufacturing & Packaging
Xcelience, a leader in early drug development, has expanded clinical trial supplies manufacturing and packaging capabilities to include four new pieces of equipment and a new fully automated packaging line.
To complement existing expertise in matrix tablet delivery systems, Xcelience added a MG Futura (capsule-filling machine for powder and pellets), LCI Multi-granulator MG-55 (extruder), QJ-230T marumerizer (spheronizer), and wurster insert (bottom spray) to the existing Glatt GPCG-3 fluid bed processor. These new pieces enable production, coating, and encapsulation of MUDF delivery systems.
“The new MG Futura is a great example of our continued commitment to add state-of-the-art technology that delivers real value to our clients,” explains Theodore Koontz, Director of Operations. “The MG Futura improves upon production times, increases overall capacity, and expands upon our existing capabilities for powders, pellets, and powder micro-dosing for inhalation systems.”
In addition, Xcelience has added a fully automated packaging line (including ink-jet coding) for primary bottling of tablets and capsules. The new packaging line enhances the speed at which batches are packaged, shortens timelines, and enhances the ability to package larger batches of drug product.
Total Page Views: 990
